Valuation: TYK Medicines, Inc

Market Cap 999M 150M 134M 124M 113M 210M 14.27B 213M 1.49B 592M 7.47B 562M 550M 23.7B P/E 2024
-38.7x
P/E 2025 -14.7x
Enterprise Value 784M 118M 106M 97.57M 88.37M 165M 11.2B 167M 1.17B 465M 5.86B 441M 432M 18.61B EV / Sales 2024
150,906x
EV / Sales 2025 -
Free-Float
59.89%
Yield 2024 *
-
Yield 2025 -
1 day-1.61%
1 week-7.14%
Current month-26.21%
1 month-25.31%
3 months-56.42%
6 months-69.81%
Current year-76.70%
1 week 3
Extreme 3
3.42
1 month 3
Extreme 3
4.56
Current year 2.41
Extreme 2.41
14.89
1 year 2.41
Extreme 2.41
15.76
3 years 2.41
Extreme 2.41
56.55
5 years 2.41
Extreme 2.41
56.55
10 years 2.41
Extreme 2.41
56.55
Manager TitleAgeSince
Chief Executive Officer 63 2017-11-01
Chief Tech/Sci/R&D Officer 60 -
Chief Tech/Sci/R&D Officer 55 2018-07-31
Director TitleAgeSince
Chairman 63 -
Director/Board Member 63 2018-05-31
Director/Board Member 60 2017-11-01
Date Insider Type Main position Quantity % Market Cap. Importance
9/16/26 Other

Chief Executive Officer

120,000 0.0316%
9/15/26 Other

Chief Executive Officer

250,000 0.0658%
9/14/26 Other

Chief Executive Officer

400,000 0.1052%
Change 5-day change 1-year change 3-year change Capi.($)
-1.61%-7.14%-80.05% - 150M
+0.65%-3.36%+36.98%+60.50% 64.14B
+1.76%+1.27%+11.82%+81.21% 55.53B
-0.94%+0.99%+10.45%+100.19% 53.03B
+2.76%+0.87%+27.92%+55.07% 45.99B
+2.00%-3.39%+17.83%+119.04% 42.45B
+1.34%-2.86%+224.43%+914.08% 40.45B
+0.64%-3.95%+11.15%+45.57% 32.25B
+29.06%+47.63%+107.12%+92.73% 34.47B
-1.68%+0.62%+24.49%-9.82% 24.23B
Average +3.40%-0.38%+39.22%+162.06% 39.27B
Weighted average by Cap. +3.40%+0.46%+49.24%+159.71%

Financials

2024 2025
Net sales 107K 16.05K 14.4K 13.31K 12.06K 22.52K 1.53M 22.8K 159K 63.4K 800K 60.22K 58.95K 2.54M -
Net income -387M -58.04M -52.07M -48.14M -43.6M -81.46M -5.53B -82.44M -576M -229M -2.89B -218M -213M -9.18B -300M -44.96M -40.34M -37.3M -33.78M -63.1M -4.28B -63.87M -446M -178M -2.24B -169M -165M -7.11B
Net Debt -284M -42.54M -38.17M -35.29M -31.96M -59.7M -4.05B -60.43M -422M -168M -2.12B -160M -156M -6.73B -214M -32.17M -28.86M -26.68M -24.17M -45.15M -3.06B -45.69M -319M -127M -1.6B -121M -118M -5.09B
Projected Income Statement - Annual - TYK Medicines, Inc
Logo TYK Medicines, Inc
TYK Medicines Inc is a China-based company primarily engaged in the research, development, and commercialization of pharmaceutical products. The Company’s main products include TY-9591, TY-302, TY-2136b, TY-2699a, TY-0540, TY-1091, TY-4028, and TY-1054. The products are primarily used to treat diseases such as breast cancer, pancreatic cancer, prostate cancer, and solid tumors. The Company primarily operates its business in the domestic market.
Employees
184
Date Price Change Volume
26-10-28 CN¥3.055 -1.61% 158,100
26-10-27 CN¥3.105 +1.80% 207,000
26-10-26 CN¥3.050 -6.15% 261,000
26-10-23 CN¥3.250 +1.88% 346,500
26-10-22 CN¥3.190 -3.04% 319,000

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - TYK Medicines, Inc
  1. Stock Market
  2. Stocks
  3. 2410 Stock